These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 21620713

  • 21. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5168-74. PubMed ID: 23867389
    [Abstract] [Full Text] [Related]

  • 22. Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors.
    Avvaru BS, Wagner JM, Maresca A, Scozzafava A, Robbins AH, Supuran CT, McKenna R.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4376-81. PubMed ID: 20605094
    [Abstract] [Full Text] [Related]

  • 23. Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII.
    Ulus R, Yeşildağ I, Tanç M, Bülbül M, Kaya M, Supuran CT.
    Bioorg Med Chem; 2013 Sep 15; 21(18):5799-805. PubMed ID: 23910989
    [Abstract] [Full Text] [Related]

  • 24. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
    Čapkauskaitė E, Zubrienė A, Smirnov A, Torresan J, Kišonaitė M, Kazokaitė J, Gylytė J, Michailovienė V, Jogaitė V, Manakova E, Gražulis S, Tumkevičius S, Matulis D.
    Bioorg Med Chem; 2013 Nov 15; 21(22):6937-47. PubMed ID: 24103428
    [Abstract] [Full Text] [Related]

  • 25. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
    Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G.
    J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236
    [Abstract] [Full Text] [Related]

  • 26. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL, Mahon BP, McKenna R, Carta F, Supuran CT.
    Bioorg Med Chem; 2016 Mar 01; 24(5):976-81. PubMed ID: 26810836
    [Abstract] [Full Text] [Related]

  • 27. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O, Biswas S, Lastra K, McKenna R, Supuran CT.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6674-80. PubMed ID: 24012377
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Parkkila S, Hilvo M, Supuran CT.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9113-20. PubMed ID: 18819811
    [Abstract] [Full Text] [Related]

  • 30. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
    Lopez M, Paul B, Hofmann A, Morizzi J, Wu QK, Charman SA, Innocenti A, Vullo D, Supuran CT, Poulsen SA.
    J Med Chem; 2009 Oct 22; 52(20):6421-32. PubMed ID: 19827837
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Carbonic anhydrase inhibitors: purification and inhibition studies of pigeon (Columba livia var. domestica) red blood cell carbonic anhydrase with sulfonamides.
    Ozensoy O, Arslan M, Supuran CT.
    J Enzyme Inhib Med Chem; 2011 Oct 22; 26(5):749-53. PubMed ID: 21476925
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
    Bozdag M, Ferraroni M, Nuti E, Vullo D, Rossello A, Carta F, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2014 Jan 01; 22(1):334-40. PubMed ID: 24300919
    [Abstract] [Full Text] [Related]

  • 37. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
    Bozdag M, Alafeefy AM, Vullo D, Carta F, Dedeoglu N, Al-Tamimi AM, Al-Jaber NA, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2015 Dec 15; 23(24):7751-64. PubMed ID: 26639945
    [Abstract] [Full Text] [Related]

  • 38. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human α- and bacterial/fungal β-carbonic anhydrases.
    Rami M, Innocenti A, Montero JL, Scozzafava A, Winum JY, Supuran CT.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5210-3. PubMed ID: 21821413
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.